Bond.az White LogoBond.az Black Logo

Liminatus Pharma Faces Nasdaq Delisting

Liminatus Pharma gets Nasdaq delisting notice after failing to meet market value requirements. Stock down 95.5%.

Alexander Gonzalez
ByAlexander Gonzalez- Senior Editor
|
0

Liminatus Pharma (NASDAQ:LIMN) received a delisting notice from Nasdaq on Tuesday. The company failed to meet the $50 million market value of listed securities and $15 million market value of publicly held shares requirement by May 18, 2026.

With a current market cap of just $10.91 million, the stock has plunged 95.5% over the past year, trading at $0.25. Bond.az data shows the company is burning cash quickly, with negative free cash flow of $9.98 million.

Unless Liminatus appeals to the Nasdaq Hearings Panel by May 27, 2026, trading will be suspended on May 29, 2026. The company intends to appeal.

More News
Yesterday / 23:10
|
943

Sara Jacobs sells Qualcomm shares up to $2M

Sara Jacobs sold Qualcomm shares worth up to $2 million. Details of the congressional trade transactions and stock performance.

0
Yesterday / 20:43
|
912

Chemung Financial declares $0.34 dividend

Chemung Financial declares $0.34 quarterly dividend. 53-year streak, 2.0% yield. Record date June 17, 2026.

0
Yesterday / 20:43
|
442

Revolution Medicines Phase 3 Results Webcast

Revolution Medicines webcast on Phase 3 RASolute 302 results for daraxonrasib in pancreatic cancer. Learn more.

0
Yesterday / 20:42
|
225

Noble appoints Halliburton CEO Jeff Miller to board

Noble Corporation appoints Halliburton CEO Jeff Miller to its board of directors, enhancing strategic planning and international business expertise.

0
Yesterday / 20:13
|
788

Vision Marine sponsors Lake Berryessa electric boat festival

Vision Marine Technologies is title sponsor of Lake Berryessa Electric Boat Festival, showcasing electric boats and watercraft.

0
Yesterday / 20:11
|
660

Altria unit to close Nashville plant

Altria's subsidiary USSTC closes Nashville plant, consolidates operations in Kentucky. Over 300 employees affected.

0
Yesterday / 18:43
|
594

Cosmos Health's Series B Warrants Expire Unexercised

Cosmos Health's Series B warrants expired unexercised, reducing dilution. Stock trades at $0.25 near 52-week low.

0
Yesterday / 18:42
|
459

KRG Stock Hits 52-Week High at 26.88 USD

Kite Realty stock hits 52-week high of 26.88 USD. Get insights on KRG performance, Q1 results, and market outlook.

0
Yesterday / 18:04
|
655

RLJ Lodging Trust Stock Hits 52-Week High at 9.52 USD

RLJ Lodging Trust stock hits 52-week high at 9.52 USD. Strong performance, 43.87% surge, and 6.32% dividend yield. Read more on Bond.az.

0
Yesterday / 18:01
|
801

Marcus $0.08 quarterly dividend declared

Marcus Corporation declares $0.08 quarterly dividend, payable June 15, 2026. Dividend growth of 14% over 12 months, yield 1.76%. Stock up 18% YTD.

0
Yesterday / 17:42
|
520

EMA accepts Teva's long-acting olanzapine application

EMA accepts Teva and Medincell's application for long-acting injectable olanzapine TEV-749 for schizophrenia treatment. Learn more about this new formulation.

0
Yesterday / 17:41
|
997

Stellantis unveils €60B strategic plan

Stellantis unveils €60 billion strategic plan for 2030, targeting €190B revenue and 7% operating margin. Learn about investments, financial targets, and brand portfolio.

0
...
Liminatus Pharma Faces Nasdaq Delisting | Bond.az